Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000929638-25-003120
Filing Date
2025-08-20
Accepted
2025-08-20 17:56:34
Documents
1
Period of Report
2025-08-08

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3693
  Complete submission text file 0000929638-25-003120.txt   5219
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Issuer) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 9920 PACIFIC HEIGHTS BLVD. SUITE 150 SAN DIEGO CA 92121
Business Address
Riezman Joshua (Reporting) CIK: 0002082518 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41827 | Film No.: 251237937